Clinical validation of the cobas 4800 HPV test for cervical screening purposes

  • D. A.M. Heideman*
  • , A. T. Hesselink
  • , J. Berkhof
  • , F. Van Kemenade
  • , W. J.G. Melchers
  • , N. Fransen Daalmeijer
  • , M. Verkuijten
  • , C. J.L.M. Meijer
  • , P. J.F. Snijders
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

169 Citations (Scopus)
12 Downloads (Pure)

Abstract

This study shows that the clinical performance and reproducibility of the cobas 4800 HPV test for high-risk human papillomavirus (HPV) detection fulfill the criteria as formulated in international guidelines of HPV test requirements for cervical screening purposes. Accordingly, the cobas 4800 HPV test can be considered clinically validated for cervical screening.

Original languageEnglish
Pages (from-to)3983-3985
Number of pages3
JournalJournal of Clinical Microbiology
Volume49
Issue number11
DOIs
Publication statusPublished - Nov 2011
Externally publishedYes

Fingerprint

Dive into the research topics of 'Clinical validation of the cobas 4800 HPV test for cervical screening purposes'. Together they form a unique fingerprint.

Cite this